Regenerative medicine for neurological disorders

Dong-Hyuk Park, David J. Eve, Yong Gu Chung, Paul R. Sanberg

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

The annual meeting of the American Society for Neural Therapy and Repair (ASNTR) has always introduced us to top-notch and up-to-date approaches for regenerative medicine related to neuroscience, ranging from stem cell-based therapy to novel drugs. The 16th ASNTR meeting focused on a variety of different topics, including the unknown pathogenesis or mechanisms of specific neurodegenerative diseases, stem cell biology, and development of novel alternative medicines or devices. Newly developed stem cells, such as amniotic epithelial stem cells and induced pluripotent stem cells, as well as well-known traditional stem cells, such as neural, embryonic, bone marrow mesenchymal, and human umbilical cord blood-derived stem cells, were reported. A number of commercialized stem cells were also covered at this meeting. Fetal neural tissues, such as ventral mesencephalon, striatum, and Schwann cells, were investigated for neurodegenerative diseases or spinal cord injury. A number of studies focused on novel methods for drug monitoring or graft tracking, and combination therapy with stem cells and medicine, such as cytokines or trophic factors. Finally, the National Institutes of Health guidelines for human stem cell research, clinical trials of commercialized stem cells without larger animal testing, and prohibition of medical tourism were big controversial issues that led to heated discussion.

Original languageEnglish
Pages (from-to)470-489
Number of pages20
JournalTheScientificWorldJournal
Volume10
DOIs
Publication statusPublished - 2010 Mar 16

Fingerprint

Regenerative Medicine
Nervous System Diseases
Stem cells
medicine
Stem Cells
stem
Neurodegenerative diseases
repair
Neurodegenerative Diseases
drug
Medical Tourism
Medicine
Repair
Stem Cell Research
Induced Pluripotent Stem Cells
Cytology
Drug Monitoring
Schwann Cells
National Institutes of Health (U.S.)
Complementary Therapies

Keywords

  • Alternative medicine
  • ASNTR
  • Neuroscience
  • Regenerative medicine
  • Stem cell
  • Transplantation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Environmental Science(all)
  • Medicine(all)

Cite this

Regenerative medicine for neurological disorders. / Park, Dong-Hyuk; Eve, David J.; Chung, Yong Gu; Sanberg, Paul R.

In: TheScientificWorldJournal, Vol. 10, 16.03.2010, p. 470-489.

Research output: Contribution to journalReview article

Park, Dong-Hyuk ; Eve, David J. ; Chung, Yong Gu ; Sanberg, Paul R. / Regenerative medicine for neurological disorders. In: TheScientificWorldJournal. 2010 ; Vol. 10. pp. 470-489.
@article{e47bc244966242dbb7a96ff400f72176,
title = "Regenerative medicine for neurological disorders",
abstract = "The annual meeting of the American Society for Neural Therapy and Repair (ASNTR) has always introduced us to top-notch and up-to-date approaches for regenerative medicine related to neuroscience, ranging from stem cell-based therapy to novel drugs. The 16th ASNTR meeting focused on a variety of different topics, including the unknown pathogenesis or mechanisms of specific neurodegenerative diseases, stem cell biology, and development of novel alternative medicines or devices. Newly developed stem cells, such as amniotic epithelial stem cells and induced pluripotent stem cells, as well as well-known traditional stem cells, such as neural, embryonic, bone marrow mesenchymal, and human umbilical cord blood-derived stem cells, were reported. A number of commercialized stem cells were also covered at this meeting. Fetal neural tissues, such as ventral mesencephalon, striatum, and Schwann cells, were investigated for neurodegenerative diseases or spinal cord injury. A number of studies focused on novel methods for drug monitoring or graft tracking, and combination therapy with stem cells and medicine, such as cytokines or trophic factors. Finally, the National Institutes of Health guidelines for human stem cell research, clinical trials of commercialized stem cells without larger animal testing, and prohibition of medical tourism were big controversial issues that led to heated discussion.",
keywords = "Alternative medicine, ASNTR, Neuroscience, Regenerative medicine, Stem cell, Transplantation",
author = "Dong-Hyuk Park and Eve, {David J.} and Chung, {Yong Gu} and Sanberg, {Paul R.}",
year = "2010",
month = "3",
day = "16",
doi = "10.1100/tsw.2010.39",
language = "English",
volume = "10",
pages = "470--489",
journal = "Scientific World Journal",
issn = "2356-6140",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Regenerative medicine for neurological disorders

AU - Park, Dong-Hyuk

AU - Eve, David J.

AU - Chung, Yong Gu

AU - Sanberg, Paul R.

PY - 2010/3/16

Y1 - 2010/3/16

N2 - The annual meeting of the American Society for Neural Therapy and Repair (ASNTR) has always introduced us to top-notch and up-to-date approaches for regenerative medicine related to neuroscience, ranging from stem cell-based therapy to novel drugs. The 16th ASNTR meeting focused on a variety of different topics, including the unknown pathogenesis or mechanisms of specific neurodegenerative diseases, stem cell biology, and development of novel alternative medicines or devices. Newly developed stem cells, such as amniotic epithelial stem cells and induced pluripotent stem cells, as well as well-known traditional stem cells, such as neural, embryonic, bone marrow mesenchymal, and human umbilical cord blood-derived stem cells, were reported. A number of commercialized stem cells were also covered at this meeting. Fetal neural tissues, such as ventral mesencephalon, striatum, and Schwann cells, were investigated for neurodegenerative diseases or spinal cord injury. A number of studies focused on novel methods for drug monitoring or graft tracking, and combination therapy with stem cells and medicine, such as cytokines or trophic factors. Finally, the National Institutes of Health guidelines for human stem cell research, clinical trials of commercialized stem cells without larger animal testing, and prohibition of medical tourism were big controversial issues that led to heated discussion.

AB - The annual meeting of the American Society for Neural Therapy and Repair (ASNTR) has always introduced us to top-notch and up-to-date approaches for regenerative medicine related to neuroscience, ranging from stem cell-based therapy to novel drugs. The 16th ASNTR meeting focused on a variety of different topics, including the unknown pathogenesis or mechanisms of specific neurodegenerative diseases, stem cell biology, and development of novel alternative medicines or devices. Newly developed stem cells, such as amniotic epithelial stem cells and induced pluripotent stem cells, as well as well-known traditional stem cells, such as neural, embryonic, bone marrow mesenchymal, and human umbilical cord blood-derived stem cells, were reported. A number of commercialized stem cells were also covered at this meeting. Fetal neural tissues, such as ventral mesencephalon, striatum, and Schwann cells, were investigated for neurodegenerative diseases or spinal cord injury. A number of studies focused on novel methods for drug monitoring or graft tracking, and combination therapy with stem cells and medicine, such as cytokines or trophic factors. Finally, the National Institutes of Health guidelines for human stem cell research, clinical trials of commercialized stem cells without larger animal testing, and prohibition of medical tourism were big controversial issues that led to heated discussion.

KW - Alternative medicine

KW - ASNTR

KW - Neuroscience

KW - Regenerative medicine

KW - Stem cell

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=77951729962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951729962&partnerID=8YFLogxK

U2 - 10.1100/tsw.2010.39

DO - 10.1100/tsw.2010.39

M3 - Review article

C2 - 20305989

AN - SCOPUS:77951729962

VL - 10

SP - 470

EP - 489

JO - Scientific World Journal

JF - Scientific World Journal

SN - 2356-6140

ER -